Prime Medicine (PRME) Other Working Capital Changes (2021 - 2026)
Prime Medicine (PRME) posted Other Working Capital Changes of -$856000.0 for Q1 2026, up 49.88% on a QoQ basis from -$1.7 million in Q4 2025, and up 72.39% year-over-year from -$496556.9 in Q1 2025.
Prime Medicine (PRME) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Prime Medicine's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$856000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 72.39% year-over-year to -$856000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.6 million (up 8.51% YoY) and the FY2025 annual result came in at -$5.4 million, up 17.01% from the prior year.
- Other Working Capital Changes was -$856000.0 for Q1 2026 at Prime Medicine, up from -$1.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.9 million in Q3 2024 and bottomed at -$2.6 million in Q4 2025.
- A 5-year average of $1.3 million and a median of $658000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes surged 299.06% — and 2025, when it tumbled 276.21%.
- Prime Medicine's Other Working Capital Changes stood at -$2.7 million in 2022, then jumped by 344.2% to $6.6 million in 2023, then slumped by 106.91% to -$454000.0 in 2024, then tumbled by 276.21% to -$1.7 million in 2025, then soared by 49.88% to -$856000.0 in 2026.
- Business Quant data shows PRME's Other Working Capital Changes at -$856000.0 in Q1 2026, -$1.7 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -856,000.00 |
| Mar 31, 2026 | -856,000.00 |
| Mar 31, 2026 | -856,000.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -454,000.00 |
| Dec 31, 2024 | -454,000.00 |
| Dec 31, 2024 | -454,000.00 |
| Sep 30, 2024 | -6.01 Mn |
| Sep 30, 2024 | -6.01 Mn |